Shrooms

Nootropic Mushrooms for Wellness Are on the Rise

Retrieved on: 
Friday, July 30, 2021

Sun and Psilo is taking the most beneficial mushrooms, and making them palatable in tinctures, capsules and soon to be gummies.

Key Points: 
  • Sun and Psilo is taking the most beneficial mushrooms, and making them palatable in tinctures, capsules and soon to be gummies.
  • The studies *on the cognitive benefits of lion's mane mushrooms are phenomenal, and when taken in conjunction with psilocybin mushrooms, it's the perfect pair."
  • In May of 2019, Denver, Colorado passed a ballot measure decriminalizing psilocybin mushrooms, more commonly known as magic mushrooms, or simply shrooms.
  • While Sun and Psilo eventually plans to enter the legal psychedelics space, the current focus is nootropic and supplemental mushrooms, including lions mane, chaga , cordyceps and more.

Levitee Labs to Commence Trading on the Canadian Securities Exchange Under the Ticker Symbol “LVT” on Wednesday, July 21st 2021

Retrieved on: 
Monday, July 19, 2021

At the opening of the market on July 21, the common shares of Levitee will begin trading under the ticker symbol LVT.

Key Points: 
  • At the opening of the market on July 21, the common shares of Levitee will begin trading under the ticker symbol LVT.
  • Levitee is a functional mushrooms company focused on the development and sale of high potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation.
  • The Levitee leadership team is composed of diverse and complementary skillsets, deriving from past successes in entrepreneurship, clinical research, venture capital, M&A, operations, technology and psychedelics.
  • The CSE (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this press release.

NGen Supercluster Supports Groundbreaking Made-in-Canada Robotic Harvesting System

Retrieved on: 
Wednesday, July 7, 2021

This project serves to highlight exactly what NGen hopes to achieve through its supercluster project funding, said Jayson Myers, CEO, NGen.

Key Points: 
  • This project serves to highlight exactly what NGen hopes to achieve through its supercluster project funding, said Jayson Myers, CEO, NGen.
  • Our partnership with NGen will accelerate commercialization of Mycionics patented robotic mushroom harvesting to solve the increasing labour shortage affecting mushroom farms globally.
  • Mycionics is dedicated to empowering mushroom farmers through the use of our robotic harvesting system that performs the labour-intensive work of harvesting mushrooms for the fresh market.
  • Mycionics globally patented robotic harvesting system continually picks, packs, and weighs mushrooms that meet fresh market quality and size requirements.

Optimi Health Supports Patient-Focused Psilocybin Advocacy by TheraPsil

Retrieved on: 
Tuesday, June 29, 2021

TheraPsil has facilitated precedent-setting and tangible progress in the fight for compassionate access to psilocybin therapy in Canada.

Key Points: 
  • TheraPsil has facilitated precedent-setting and tangible progress in the fight for compassionate access to psilocybin therapy in Canada.
  • The primary services of TheraPsil are patient-rights advocacy, assessment, and referral - connecting patients with exemptions with therapists trained in psilocybin assisted therapy.
  • Every dollar donated will help TheraPsil advocate for psilocybin regulations in Canada through public education, research, and patient advocacy.
  • On Behalf of the Board of Directors, Optimi Health Corp.
    Optimi is developing a sophisticated mushroom brand that focuses on the health and wellness markets.

NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products

Retrieved on: 
Thursday, June 10, 2021

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FSE: 6UF) ("NeonMind"), is pleased to announce that Vitasave has agreed to carry all four of NeonMind's functional mushroom infused coffees through Vitasave's eCommerce platform.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - June 10, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FSE: 6UF) ("NeonMind"), is pleased to announce that Vitasave has agreed to carry all four of NeonMind's functional mushroom infused coffees through Vitasave's eCommerce platform.
  • With two retail locations and growing, Vitasave carries a broad product mix with over 7,500 natural health products across more than 250 brands, including vitamins, supplements, food, pet care and lifestyle products.
  • This week, NeonMind shipped out deliveries of all four of its functional mushroom infused coffees to two Vitasave warehouses in Ontario and British Columbia, Canada.
  • The NeonMind coffee product line delivers excellent taste along with the functional mushrooms that can be incorporated into a daily ritual."

Pharmadrug's Supersmart Launches Psilocybin Online Retail Platform in the Netherlands

Retrieved on: 
Monday, June 7, 2021

The European Slim Winkel online store will sell psilocybin truffles as well as functional mushrooms in The Netherlands.

Key Points: 
  • The European Slim Winkel online store will sell psilocybin truffles as well as functional mushrooms in The Netherlands.
  • The website will also service other parts of Europe, but without the access to psilocybin truffles.
  • Secondly, it will enable the company to continue to curate quality products, which will eventually include its own branded psilocybin truffles in The Netherlands.
  • Thirdly, it will enable Super Smart to continue to develop its psilocybin supply chain.

Reishi Mushroom Market to Generate $5.06 Bn, Globally, by 2027 at 8.1% CAGR: AMR

Retrieved on: 
Tuesday, April 13, 2021

Moreover, rise in consumer spending and health consciousness among consumers supplement the market growth.

Key Points: 
  • Moreover, rise in consumer spending and health consciousness among consumers supplement the market growth.
  • However, high price of reishi mushrooms hinders the market growth.
  • However, the powder segment held the lion\'s share in 2019, accounting for around three-fifths of the global reishi mushroom market, as it offers essential nutrients as compared to its fresh version.\nBy nature, the conventional segment dominated the market in 2019, contributing to more than three-fifths of the global reishi mushroom market, as conventionally-sourced mushrooms are economical and widely used in industrial production.
  • However, the market across Asia-Pacific is anticipated to manifest the highest CAGR of 7.3% during the forecast period, owing totremendous popularity and substantial consumption of reishi mushroom products in the region.\n'

Reishi Mushroom Market to Generate $5.06 Bn, Globally, by 2027 at 8.1% CAGR: AMR

Retrieved on: 
Tuesday, April 13, 2021

Moreover, rise in consumer spending and health consciousness among consumers supplement the market growth.

Key Points: 
  • Moreover, rise in consumer spending and health consciousness among consumers supplement the market growth.
  • However, high price of reishi mushrooms hinders the market growth.
  • However, the powder segment held the lion\'s share in 2019, accounting for around three-fifths of the global reishi mushroom market, as it offers essential nutrients as compared to its fresh version.\nBy nature, the conventional segment dominated the market in 2019, contributing to more than three-fifths of the global reishi mushroom market, as conventionally-sourced mushrooms are economical and widely used in industrial production.
  • However, the market across Asia-Pacific is anticipated to manifest the highest CAGR of 7.3% during the forecast period, owing totremendous popularity and substantial consumption of reishi mushroom products in the region.\n'

Gaia Herbs Launches New Line of Mushroom Capsules to Support Whole-Body Health & Maintain Long-Term Wellness*

Retrieved on: 
Tuesday, March 16, 2021

Gaia Herbs , a leading natural herbal products brand in the United States, announces the launch of its new line of six mushroom capsule supplements that help to support whole-body health and maintain wellness: Respiratory Mushroom Blend , Immune Mushroom Blend , Reishi Mushroom , Lions Mane Mushroom , Cordyceps Mushroom , and Turkey Tail Mushroom .

Key Points: 
  • Gaia Herbs , a leading natural herbal products brand in the United States, announces the launch of its new line of six mushroom capsule supplements that help to support whole-body health and maintain wellness: Respiratory Mushroom Blend , Immune Mushroom Blend , Reishi Mushroom , Lions Mane Mushroom , Cordyceps Mushroom , and Turkey Tail Mushroom .
  • * These products are designed to help maintain lung, immune, heart, brain and neurological health; offer energy and stamina support; stress support; and support for healthy liver function, respectively.
  • View the full release here: https://www.businesswire.com/news/home/20210316005209/en/
    Gaia Herbs New Mushroom Capsules (Photo: Business Wire)
    For over 30 years, Gaia Herbs has been connecting people, plants, and planet to create healing.
  • Gaia Herbs newest products harness the age-old tradition of using mushrooms to help maintain whole-body health and wellness.

Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT

Retrieved on: 
Tuesday, March 9, 2021

Optimi instituted a program in 2020 to identify and engage with a suitable partner in its quest to become one of the first companies to utilize natural psilocybin mushrooms as a primary component for product formulization and requisite clinical trial efforts.

Key Points: 
  • Optimi instituted a program in 2020 to identify and engage with a suitable partner in its quest to become one of the first companies to utilize natural psilocybin mushrooms as a primary component for product formulization and requisite clinical trial efforts.
  • Optimis JJ Wilson, (Board Chair), notes, In order to use naturally harvested psilocybin mushrooms for a clinical trial, the psilocybin must first be grown in a GMP grade facility.
  • The IMPACT program provides Optimi expert clinical support towards commercializing proposed psilocybin-based formulations through the conduct of clinical trials and expert assistance towards securing regulatory approval.
  • On Behalf of the Board of Directors, Optimi Health Corp.
    Optimi is developing a sophisticated mushroom brand that focuses on the health and wellness markets.